Video

Q&A With David Bernstein From the University of Cincinnati: Sublingual Allergy Treatment Provides Alternative To Shots

Author(s):

For patients with severe seasonal allergies the regularly available medications may not be enough to help their symptoms while the prospect of shots may be prohibitive enough to keep them from getting shots. A newly approved treatment could provide an alternative to the needle.

For patients with severe seasonal allergies the regularly available medications may not be enough to help their symptoms while the prospect of shots may be prohibitive enough to keep them from getting shots. A newly approved treatment could provide an alternative to the needle.

David Bernstein, MD, from the University of Cincinnati discussed what this new treatment method could mean to patients and healthcare providers during the American College of Allergy, Asthma, and Immunology's annual meeting in San Antonio.

Related Videos
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
A. Sidney Barritt, MD | Credit: UNC School of Medicine
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
© 2024 MJH Life Sciences

All rights reserved.